THE GROUP .
Working on biocompatible nanoparticle systems for use as MRI contrast agents.
Working on functionalised silica nanoparticles for optical and Magnetic Resonance Imaging.
Working on a novel bottom-up approach for the synthesis of group III-V semiconductor nanoparticles.
Working on parmagnetic inorganic-organic hybrid nanoparticle imaging systems.
Working on electrochemical microfluidics and kinetics quantification in diagnostics.
Investigating metabolic plasticity in prostate cancer bone metastases and novel circulating tumour cell (CTC) isolation methodology. More specifically, developing nanoparticle and microfluidic-based approaches for detection and isolation of prostate cancer CTCs.
Developing novel electrochemical ion sensing methodologies, and exploring the ion sensing performance of a range of supramolecular hosts in solution, and at receptive films.
Working on the electrochemical modification of proteins in vitro and in cellulo.
Working on the establishment of highly sensitive circulating tumour cell assays
Working on redox capacitive assaying of biomarkers for the early detection of Parkinson's.
Working on developing new exosomal diagnostic assays relevant to Parkinsons.
Working on NOT chasing wild animals and improving" the group leaders 10k time
FORMER MEMBERS IN ACADEMIA .
Multiple previous members of the group are now in academic positions around the world, including:
- Dr Jan Tkac (Professor of Chemistry, Slocak Academy of Sciences, Slovakia)
- Dr Xiliang Luo (Professor of Chemistry, Qingdao University of Science and Technology)
- Dr Joshua Lehr (University of Salford)
- Dr Gemma Louise-Davies (Lecturer in Chemistry, UCL, London)
- Dr Mohamed Sharafeldin (University of Otago, New Zealand)
